Horizon 2020 Dedicated SME Instrument - Health

Provides 0.5 - 2.5M € in subsidies for development and demonstration within:

About Horizon 2020 Dedicated SME Instrument - Health

The Horizon 2020 Dedicated SME Instrument directly supports European small and medium-sized enterprises with a strong desire to develop, grow, and internationalize their most innovative ideas. The instrument is relevant for high-tech and research driven companies as well as service companies, and SMEs applying in a consortium or alone. With a successful application to the program, companies will receive:

  • Phase 1: A lump sum of EUR 50,000 towards proof-of-concept and feasibility studies
  • Phase 2: EUR 0.5-2.5M towards innovation development and demonstration activities
  • Support of up to 70% of total project cost

Possibilities with Horizon 2020 SME

Horizon 2020 SME offers funding opportunities for SMEs within a variety of industries, and support is given to the development of innovative ideas to market ready products, processes or services. The program has an overall budget of EUR 3BN which will be distributed to innovative projects in two separate phases.

Phase 1 funding is aimed at exploring and assessing the technical feasibility and commercial potential of breakthrough innovation.

  • Activities include risk assessment, market study, user involvement, Intellectual Property (IP) management, innovation strategy development, partner search, feasibility of concept etc.

Phase 2 funding is aimed at innovation projects supported by a sound and strategic business plan (potentially made possible by phase 1 funding) aimed at commercialisation.

  • Activities include prototyping, miniaturisation, scaling-up, design, performance verification, testing, demonstration, development of pilot lines, market replication, etc.

Requirements for Horizon 2020 SME

There are three primary requirements for a project to be eligible for support from Horizon 2020 SME:

  • Projects need at least one participating SME to apply (An SME has fewer than 250 employees and an annual turnover not exceeding EUR 50M, and/or an annual balance sheet total not exceeding EUR 43M). SMEs may apply alone.
  • No parallel submission or implementation (phase 1 and phase 2) is possible.
  • Phase 2 proposals must be based on an elaborate business plan, with particular attention given to IP protection and ownership as well as commercial exploitation.

Upcoming deadlines

Below are the upcoming deadlines for Horizon 2020 Dedicated SME Instrument. Expect 1-2 months for the proposal writing process.

07
sep

The healthcare biotechnology sector offers huge business and commercial opportunities; however it also requires heavy and risky investments which are often lacking in Europe, hampering the development of the industry.

Cell technologies in medical applications
​Cell technologies include cell manufacturing (culture, multiplication, scale-up and automation), preservation, banking and transport; identification, cell sorting and delivery, imaging, tracking, process and quality control; genetic engineering and gene editing; production of therapeutic biomolecules.

07
sep

The challenge is to help overcome the current gaps in exploitation of promising research results in ICT for Health, Well-being and Ageing well and to stimulate increased availability and market uptake of relevant ICT products and services. This concerns both interoperable and secure eHealth solutions for consumers and institutional healthcare delivery building on standards and new ICT solutions and innovation ecosystems for ageing well building on open software platforms. Particular attention will be given to potential for disruptive innovation and fast market up-take in ICT for health, wellbeing and ageing well.

13
oct

The healthcare biotechnology sector offers huge business and commercial opportunities; however it also requires heavy and risky investments which are often lacking in Europe, hampering the development of the industry.

Cell technologies in medical applications
​Cell technologies include cell manufacturing (culture, multiplication, scale-up and automation), preservation, banking and transport; identification, cell sorting and delivery, imaging, tracking, process and quality control; genetic engineering and gene editing; production of therapeutic biomolecules.

09
nov

The healthcare biotechnology sector offers huge business and commercial opportunities; however it also requires heavy and risky investments which are often lacking in Europe, hampering the development of the industry.

Cell technologies in medical applications
​Cell technologies include cell manufacturing (culture, multiplication, scale-up and automation), preservation, banking and transport; identification, cell sorting and delivery, imaging, tracking, process and quality control; genetic engineering and gene editing; production of therapeutic biomolecules.

18
jan

The healthcare biotechnology sector offers huge business and commercial opportunities; however it also requires heavy and risky investments which are often lacking in Europe, hampering the development of the industry.

Cell technologies in medical applications
​Cell technologies include cell manufacturing (culture, multiplication, scale-up and automation), preservation, banking and transport; identification, cell sorting and delivery, imaging, tracking, process and quality control; genetic engineering and gene editing; production of therapeutic biomolecules.

18
jan

The healthcare biotechnology sector offers huge business and commercial opportunities; however it also requires heavy and risky investments which are often lacking in Europe, hampering the development of the industry.

Clinical research for the validation of biomarkers and/or diagnostic medical devices.
Biomarkers are used in clinical practice to indicate both normal and pathological conditions. They are also used for predictive or prognostic purposes. They are being used increasingly in medicine and many potential new biomarkers are proposed every year. However, only a few of these have been validated for clinical use. To achieve validation a robust analytical method is required and a link to a pertinent clinical process or endpoint needs to be demonstrated.

15
feb

The healthcare biotechnology sector offers huge business and commercial opportunities; however it also requires heavy and risky investments which are often lacking in Europe, hampering the development of the industry.

Cell technologies in medical applications
​Cell technologies include cell manufacturing (culture, multiplication, scale-up and automation), preservation, banking and transport; identification, cell sorting and delivery, imaging, tracking, process and quality control; genetic engineering and gene editing; production of therapeutic biomolecules.

06
apr

The healthcare biotechnology sector offers huge business and commercial opportunities; however it also requires heavy and risky investments which are often lacking in Europe, hampering the development of the industry.

Cell technologies in medical applications
​Cell technologies include cell manufacturing (culture, multiplication, scale-up and automation), preservation, banking and transport; identification, cell sorting and delivery, imaging, tracking, process and quality control; genetic engineering and gene editing; production of therapeutic biomolecules.

06
apr

The healthcare biotechnology sector offers huge business and commercial opportunities; however it also requires heavy and risky investments which are often lacking in Europe, hampering the development of the industry.

Clinical research for the validation of biomarkers and/or diagnostic medical devices.
Biomarkers are used in clinical practice to indicate both normal and pathological conditions. They are also used for predictive or prognostic purposes. They are being used increasingly in medicine and many potential new biomarkers are proposed every year. However, only a few of these have been validated for clinical use. To achieve validation a robust analytical method is required and a link to a pertinent clinical process or endpoint needs to be demonstrated.

03
may

The healthcare biotechnology sector offers huge business and commercial opportunities; however it also requires heavy and risky investments which are often lacking in Europe, hampering the development of the industry.

Cell technologies in medical applications
​Cell technologies include cell manufacturing (culture, multiplication, scale-up and automation), preservation, banking and transport; identification, cell sorting and delivery, imaging, tracking, process and quality control; genetic engineering and gene editing; production of therapeutic biomolecules.

01
jun

The healthcare biotechnology sector offers huge business and commercial opportunities; however it also requires heavy and risky investments which are often lacking in Europe, hampering the development of the industry.

Cell technologies in medical applications
​Cell technologies include cell manufacturing (culture, multiplication, scale-up and automation), preservation, banking and transport; identification, cell sorting and delivery, imaging, tracking, process and quality control; genetic engineering and gene editing; production of therapeutic biomolecules.

01
jun

The healthcare biotechnology sector offers huge business and commercial opportunities; however it also requires heavy and risky investments which are often lacking in Europe, hampering the development of the industry.

Clinical research for the validation of biomarkers and/or diagnostic medical devices.
Biomarkers are used in clinical practice to indicate both normal and pathological conditions. They are also used for predictive or prognostic purposes. They are being used increasingly in medicine and many potential new biomarkers are proposed every year. However, only a few of these have been validated for clinical use. To achieve validation a robust analytical method is required and a link to a pertinent clinical process or endpoint needs to be demonstrated.

06
sep

The healthcare biotechnology sector offers huge business and commercial opportunities; however it also requires heavy and risky investments which are often lacking in Europe, hampering the development of the industry.

Cell technologies in medical applications
​Cell technologies include cell manufacturing (culture, multiplication, scale-up and automation), preservation, banking and transport; identification, cell sorting and delivery, imaging, tracking, process and quality control; genetic engineering and gene editing; production of therapeutic biomolecules.

18
oct

The healthcare biotechnology sector offers huge business and commercial opportunities; however it also requires heavy and risky investments which are often lacking in Europe, hampering the development of the industry.

Cell technologies in medical applications
​Cell technologies include cell manufacturing (culture, multiplication, scale-up and automation), preservation, banking and transport; identification, cell sorting and delivery, imaging, tracking, process and quality control; genetic engineering and gene editing; production of therapeutic biomolecules.

18
oct

The healthcare biotechnology sector offers huge business and commercial opportunities; however it also requires heavy and risky investments which are often lacking in Europe, hampering the development of the industry.

Clinical research for the validation of biomarkers and/or diagnostic medical devices.
Biomarkers are used in clinical practice to indicate both normal and pathological conditions. They are also used for predictive or prognostic purposes. They are being used increasingly in medicine and many potential new biomarkers are proposed every year. However, only a few of these have been validated for clinical use. To achieve validation a robust analytical method is required and a link to a pertinent clinical process or endpoint needs to be demonstrated.

08
nov

The healthcare biotechnology sector offers huge business and commercial opportunities; however it also requires heavy and risky investments which are often lacking in Europe, hampering the development of the industry.

Cell technologies in medical applications
​Cell technologies include cell manufacturing (culture, multiplication, scale-up and automation), preservation, banking and transport; identification, cell sorting and delivery, imaging, tracking, process and quality control; genetic engineering and gene editing; production of therapeutic biomolecules.

Can your project get funding from Horizon 2020 Dedicated SME Instrument?

Let us contact you to discuss your possibilities within Horizon 2020 Dedicated SME Instrument - Health

Can your project get funding?

We can tell you if your project is suited for public funding. Tell us a little bit about your project we can help you identify the funding potential.

Tell us about your project

or call (+45) 61 60 75 08

We help you succeed

We help companies obtain public funding by converting good projects to well-prepared applications.

Our services cover the entire application process:

Identifying funding opportunities
We identifying your best funding opportunities
Planning and scoping your project
We plan and scope your project to meet demands
Writing the successful application
We write the application that increases your chance of success